GSA Capital Partners’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $360K | Buy |
|
|||||
|
2024
Q3 | $505K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $272K | Buy |
|
|||||
|
2019
Q4 | $346K | Buy |
|
|||||
|
2019
Q3 | $272K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $2.07M | Buy |
|
|||||
|
2018
Q4 | $1.49M | Buy |
|
|||||
|
2018
Q3 | $1.09M | Sell |
|
|||||
|
2018
Q2 | $2.27M | Sell |
|
|||||
|
2018
Q1 | $2.39M | Sell |
|
|||||
|
2017
Q4 | $3.4M | Buy |
|
|||||
|
2017
Q3 | $2.64M | Buy |
|
|||||
|
2017
Q2 | $1.87M | Sell |
|
|||||
|
2017
Q1 | $2.34M | Sell |
|
|||||
|
2016
Q4 | $2.51M | Sell |
|
|||||
|
2016
Q3 | $3.13M | Buy |
|
|||||
|
2016
Q2 | $4.44M | Buy |
|
|||||
|
2016
Q1 | $4.84M | Buy |
|
|||||
|
2015
Q4 | $5.43M | Buy |
|
|||||
|
2015
Q3 | $2.87M | Buy |
|
|||||
|
2015
Q2 | $1.64M | Sell |
|
|||||
|
2015
Q1 | $2.13M | Sell |
|
|||||
|
2014
Q4 | $2.49M | Buy |
|
|||||
|
2014
Q3 | $1.67M | Buy |
|
|||||
|
2014
Q2 | $408K | Sell |
|
|||||
|
2014
Q1 | $421K | Sell |
|
|||||
|
2013
Q4 | $629K | Sell |
|
|||||
|
2013
Q3 | $2.1M | Buy |
|
|||||
|
2013
Q2 | $551K | Buy |
|